US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist

0.5978
+0.0181+3.12%

Trading Apr 11 10:03 ET

27.94MMarket Cap-0.66P/E (TTM)

Reviva Pharmaceuticals Stock Forum

This_Guy

Mar 31 00:19

$Reviva Pharmaceuticals (RVPH.US)$
Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress
Reviva Pharmaceuticals (NASDAQ: RVPH) has announced it will present topline data from the long-term open label extension portion of its Phase 3 RECOVER study for brilaroxazine in schizophrenia treatment at the 2025 SIRS Congress in Chicago.
The presentation, titled 'Brilaroxazine Phase 3 Recover 52-Week Open-Label Evaluation of Efficac...

Clintzilla

Jan 16 23:05

$Reviva Pharmaceuticals (RVPH.US)$ Institutions steal the whole float yet?

iDontKnowHowToTrade

Jan 2 23:23

$Reviva Pharmaceuticals (RVPH.US)$ LET IT FLYYY

Trytosaveabit

Dec 17, 2024 06:25

Of course! Hehehe

$Reviva Pharmaceuticals (RVPH.US)$ Reviva Announces Proposed Public Offering
GlobeNewswire· 6 mins ago

Jaguar8

Dec 16, 2024 21:00

NEWS

$Reviva Pharmaceuticals (RVPH.US)$
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
Monday, 16th December at 8:00 am
– Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year –
– Generally well-tolerated with low rates of adverse events and discontinuation –
– Full data set from open-label extension (OLE) of R...

Jaguar8

Dec 16, 2024 10:58

🔶December 2024 Upcoming Catalysts. Save it. In alphabetical order

$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...